Dr. Desmond Pink and Dr. Argo Basu of Nanostics Inc. share their groundbreaking work in prostate cancer screening which has led them to the creation of the ClarityDX Prostate test, which uses machine learning and blood testing to improve the predictive power of the presence of prostate cancer compared to traditional PSA testing. This new test can save health care millions of dollars and improve the diagnosis and treatment of patients. The two are on hand to share their findings and their excitement for the future of prostate cancer diagnosis.